Evaluating the Role of KRAS and NRAS 3' Untranslated Region Polymorphisms in Susceptibility and Clinical Features of Laryngeal Squamous Cell Carcinoma. The gene discussed is KRAS; the disease is laryngeal squamous cell carcinoma.